XPH - How to Identify the Opportunity and Potential Pitfalls in Spdr S&p Pharmaceuticals
This Spdr S&p Pharmaceuticals (NYSE: XPH) report helps investors and traders identify both opportunity, and potential red flags, by using the price action of the stock. The trading plans for XPH have risk controls, and that make these observations both opportunistic and defensive, but the data on this page is not real time. If you want a real time update, or a different stock, please get one here Unlimited Real Time Reports .
Technical Summary
Term ? | Near | Mid | Long |
---|---|---|---|
Bias | |||
Weak | |||
Neutral | |||
Strong | |||
P1 | |||
0 | |||
0 | |||
50.21 | |||
P2 | |||
52.77 | |||
52.76 | |||
52.90 | |||
P3 | |||
54.31 | |||
54.05 | |||
55.58 |
Long Term Trading Plans for XPH
March 3, 2021, 2:45 pm ET
The Technical Summary and Trading Plans for XPH help you determine where to buy, sell, and set risk controls. The data is best used in conjunction with our Market Analysis and Stock Correlation Filters too, because those help us go with the flow of the market as well. Going with the flow is extremely important, so review our Market Analysis with this XPH Report.
XPH - (Long) Support Plan
The technical summary data tells us to buy XPH near 50.21 with an upside target of 52.90. This data also tells us to set a stop loss @ 50.06 to protect against excessive loss in case the stock begins to move against the trade. 50.21 is the first level of support below 52.46 , and by rule, any test of support is a buy signal. In this case, support 50.21 would be being tested, so a buy signal would exist.
XPH - (Short) Resistance Plan
The technical summary data is suggesting a short of XPH as it gets near 52.90 with a downside target of 50.21. We should have a stop loss in place at 53.05though. 52.90 is the first level of resistance above 52.46, and by rule, any test of resistance is a short signal. In this case, if resistance 52.90 is being tested, so a short signal would exist.